22157.jpg
Worldwide Mammography Devices Industry to 2026 - Key Drivers and Challenges
28 janv. 2022 06h03 HE | Research and Markets
Dublin, Jan. 28, 2022 (GLOBE NEWSWIRE) -- The "Global Mammography Devices Market, By Product Type (Full-field Digital Mammography, Film-screen Mammogram, Breast Tomosynthesis), By Technology...
Breast Cancer Awaren
Breast Cancer Awareness Month
09 sept. 2021 17h58 HE | Solis Mammography
Dallas, TX, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Breast cancer does not discriminate. No one expects to be diagnosed with this disease, particularly women under the age of 40. According to the...
22157.jpg
Insights on the Mammography Systems Global Market to 2029 - Booming Healthcare Industry is Driving Growth
16 juin 2021 07h48 HE | Research and Markets
Dublin, June 16, 2021 (GLOBE NEWSWIRE) -- The "Mammography Systems Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and...
22157.jpg
Insights on the Breast Imaging Global Market to 2025 - Key Drivers and Restraints
03 sept. 2020 07h59 HE | Research and Markets
Dublin, Sept. 03, 2020 (GLOBE NEWSWIRE) -- The "Breast Imaging Market - Forecasts from 2020 to 2025" report has been added to ResearchAndMarkets.com's offering. The breast imaging market is...
CorporateSeal- Gold Small size.jpg
Women’s Choice Award® Announces 2017 America’s Best Breast Centers
10 oct. 2017 09h45 HE | Women's Choice Award
FT. LAUDERDALE, Fla., Oct. 10, 2017 (GLOBE NEWSWIRE) -- The Women’s Choice Award®, America’s trusted referral source for the best in healthcare, has announced its 2017 America’s Best Breast Centers...
BREVAGen reclassified 64 percent of above average Gail risk subjects
CONTEMPORARY OBSTETRICS AND GYNECOLOGY OF DAYTON ANNOUNCES THE AVAILABILITY OF STATE-OF-THE-ART BREAST CANCER RISK ASSESSMENT TEST
30 sept. 2013 10h34 HE | Genetic Technologies Group
DAYTON, Ohio, Sept. 30, 2013 (GLOBE NEWSWIRE) -- Contemporary Obstetrics & Gynecology, part of the Providence Medical Group, today announced the availability of the BREVAGen™ predictive risk...
BREVAGen Logo_edit
OB/GYN ASSOCIATES IN LEWISBURG, PA ANNOUNCES THE AVAILABILITY OF STATE-OF-THE-ART BREAST CANCER RISK ASSESSMENT TEST
26 août 2013 13h06 HE | Genetic Technologies Group
SUNBURY, PA., Aug. 26, 2013 (GLOBE NEWSWIRE) -- Russell Stankiewicz, MD, FACOG, CCD, NMCP, is pleased to announce that OB/GYN Associates of Lewisburg, P.C. in Lewisburg, PA is now offering the...
Atossa Genetics, Inc. Announces Filing of S-1 Registration Statement
01 oct. 2010 09h30 HE | Atossa Genetics, Inc.
SEATTLE, WA--(Marketwire - October 1, 2010) - Atossa Genetics, Inc., a privately-held healthcare company focused on the development and marketing of novel cellular and molecular diagnostic risk...
Atossa Genetics, Inc. Appoints Robert L. Kelly as President
25 mai 2010 09h00 HE | Atossa Genetics, Inc.
SEATTLE, WA--(Marketwire - May 25, 2010) -  Atossa Genetics, Inc., a privately-held healthcare company focused on the development and marketing of leading edge and unique cellular and molecular...
Atossa Genetics, Inc. Appoints Edward Sauter, M.D., Ph.D., to Its Scientific Advisory Board
25 févr. 2010 11h00 HE | Atossa Genetics, Inc.
SEATTLE, WA--(Marketwire - February 25, 2010) -  Atossa Genetics, Inc., a privately-held healthcare company focused on the development and marketing of novel cellular and molecular diagnostic...